Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR
Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
ABG-WTT Global Life Science Capital Partners GP Ltd (CIK 1832108) reported $8.6M across 2 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: CBLL ($5.4M, 62.61%), RPID ($3.2M, 37.39%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | CBLL | CERIBELL INC | $5.4M | 62.61% | 275,328 | Trimmed |
| 2 | RPID | RAPID MICRO BIOSYSTEMS INC | $3.2M | 37.39% | 1.8M | Hold |
Source: SEC Form 13F filings · as of 2026-06-30